ArticleNeurology. Clinical practice2020
Looking ahead: The risk of neurologic complications due to COVID-19.
Article in Neurology. Clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.
- Neurological involvement of coronavirus disease 2019: a systematic review.Journal of neurology · 2020Pooled it
- Article
- COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pandemic.Brain disorders (Amsterdam, Netherlands) · 2023Review
- Responding to COVID-19 in social work field education in Australia, New Zealand and the United States.International social work · 2023Article
- COVID-19 and abducens nerve palsy in a 9-year-old girl-case report.Italian journal of pediatrics · 2022Article
- SARS-CoV-2 Morbidity in the CNS and the Aged Brain Specific Vulnerability.International journal of molecular sciences · 2022Review
- COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study.Multiple sclerosis and related disorders · 2021Article
- Secondary Impacts of COVID-19 Pandemic in Fatigue, Self-Compassion, Physical and Mental Health of People with Multiple Sclerosis and Caregivers: The Teruel Study.Brain sciences · 2021Article
- Risk of contracting SARS-CoV-2 (COVID-19) from hospital admission and the impact of protection efforts on acute stroke treatment.Clinical neurology and neurosurgery · 2021Article
- Diffuse functional brain disconnection syndrome in critically ill patients with COVID-19.Journal of infection and public health · 2021Article
- Chemosensory Systems in COVID-19: Evolution of Scientific Research.ACS chemical neuroscience · 2021Review
- Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021Review
- Relevance and Clinical Significance of Magnetic Resonance Imaging of Neurological Manifestations in COVID-19: A Systematic Review of Case Reports and Case Series.Brain sciences · 2020Review
- Article
- Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.Brain, behavior, and immunity · 2020Observational
- Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging Perspective.AJNR. American journal of neuroradiology · 2020Article
- Spectrum of neuropsychiatric manifestations in COVID-19.Brain, behavior, and immunity · 2020Article
- The Neurologic Manifestations of Coronavirus Disease 2019.Journal of neurology research · 2020Review
- COVID-19 related stress exacerbates common physical and mental pathologies and affects treatment (Review).Experimental and therapeutic medicine · 2020Article
- Post-infectious neurological disorders.Therapeutic advances in neurological disorders · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid spread of Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has become a public health emergency of international concern. The outbreak was characterized as a pandemic by the World Health Organization (WHO) in March 2020. The most characteristic symptom of patients with COVID-19 is respiratory distress. Some patients may also show neurologic signs and symptoms ranging from headache, nausea, vomiting, and confusion to anosmia, ageusia, encephalitis, and stroke. Coronaviruses are known pathogens with neuroinvasive potential. There is increasing evidence that coronavirus infections are not always confined to the respiratory tract. CNS involvement can occur in susceptible individuals and may contribute overall morbidity and mortality in the acute setting. In addition, postinfectious, immune-mediated complications in the convalescent period are possible. Awareness and recognition of neurologic manifestations is essential to guide therapeutic decision-making because the current outbreak continues to unfold.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.